Selank

Selank is studied as a structural counterpart to Semax, examined in research settings for its distinct peptide behavior within the same broader category of neuroactive compounds.

Every Obsidian release passes through the same two-stage process without exception: tested at the source, then independently verified by an accredited U.S. laboratory. Consistency is not optional.